IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q2 2019 Holdings

Filed 2019-08-14 | 10 holdings | $44.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$41.3M176,55693.5%
Avanos Medical Inc(AVNS)COM05350V106$2.6M59,3785.9%
Mckesson Corp(MCK)COM58155Q103$50.2K373,2970.1%
United Therapeutics Corp(UTHR)COM91307C102$43.0K550,2990.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$40.5K479,5760.1%
Amgen Inc(AMGN)COM031162100$39.7K215,4020.1%
Gilead Sciences Inc(GILD)COM375558103$37.2K551,2370.1%
Elanco Animal Health Inc(ELAN)COM28414H103$30.1K891,8510.1%
RTI Surgical HDS IncCOM74975N105$16.7K3,917,7440.0%
Invacare CorpCOM461203101$6.9K1,331,4090.0%